<DOC>
	<DOCNO>NCT00606359</DOCNO>
	<brief_summary>Primary Objective : To describe immunogenicity injection investigational inactivate , split-virion influenza vaccine 21 day vaccination 18 60 year old renal transplant subject identify non-responder previous vaccination IM reference vaccine ( Vaxigrip® ) . Secondary Objective : To describe safety injection investigational inactivate , split-virion influenza vaccine 18 60 year old renal transplant subject identify non-responder previous vaccination IM reference vaccine</brief_summary>
	<brief_title>Immunogenicity Inactivated Split-Virion Influenza Vaccine Renal Transplant Subjects</brief_title>
	<detailed_description>The trial multicenter , randomize , control trial renal transplant subject age 18 60 year non-responders vaccination reference vaccine . Subjects randomize receive either 2007-2008 15 µg investigational vaccine 2007-2008 IM reference vaccine .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Orthomyxoviridae Infections</mesh_term>
	<criteria>Able attend schedule visit comply trial procedure . Subject renal transplant least 6 month . Subject stable renal function , i.e . variation creatinin value &lt; 20 % creatinin clearance estimate accord Cockroft Gault calculation &gt; 20 mL/min 3 month precede inclusion . Aged 18 59 year day screen visit . Informed Consent Form sign . Subject entitle national social security . Subject immunosuppressive therapy . For woman , inability bear child negative urine pregnancy test . Subject nonresponder previous IM vaccination 20062007 Northern Hemisphere Vaxigrip® formulation . Subject sign transplant kidney reject within 3 month precede vaccination accord medical practice . Systemic hypersensitivity vaccine component history lifethreatening reaction trial vaccine vaccine contain substance . Febrile illness ( oral temperature ≥ 37.5°C , rectal equivalent temperature ≥ 38.0°C ) day inclusion . Breastfeeding . Participation another clinical trial 4 week precede trial vaccination . Planned participation another clinical trial present trial period . Congenital immunodeficiency , anticancer chemotherapy radiation therapy within precede 6 month . Chronic illness , except renal failure renal disorder , stage could interfere trial conduct completion . Current abuse alcohol drug addiction may interfere subject 's ability comply trial procedure . Blood bloodderived product receive past 3 month . Any vaccination 4 week precede trial vaccination . Vaccination plan 4 week follow trial vaccination . Thrombocytopenia bleed disorder contraindicate intramuscular ( IM ) vaccination Previous vaccination influenza precede 6 month . Subject deprive freedom administrative court order , emergency setting , hospitalize without his/her consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Orthomyxoviridae Infections</keyword>
	<keyword>Renal Transplant</keyword>
</DOC>